Vascular smooth muscle cell growth arrest on blockade of thrombospondin- 1 requires p21(Cip1/WAF1)

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Chen, Donghui ^a   Guo, Kun ^a   Yang, Jihong ^a   Frazier, William A ^c   Isner, Jeffrey M ^a   Andrés, Vicente ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle control; Extracellular matrix; p21(Cip1 WAF1); Thrombospondin

Indexed keywords

PROTEIN P21; THROMBOSPONDIN 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032888184     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.3.h1100     Document Type: Article

References (59)

1. Andrés, V., and K. Walsh. Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132: 657-666, 1996.
2. Assoian, R. K., and E. E. Marcantonio. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J. Clin. Invest. 98: 2436-2439, 1996.
3. Bornstein, P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130: 503-506, 1995.
4. Bornstein, P., K. O'Rourke, K. Wikstrom, F. W. Wolf, R. Katz, P. Li, and V. M. Dixit. A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J. Biol. Chem. 266: 12821-12824, 1991.
5. Carey, D. J. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu. Rev. Physiol. 53: 161-177, 1991.
6. Chang, M. W., E. Barr, M. M. Lu, K. Barton, and J. M. Leiden. Adenovirus-mediated over-expression of the cyclin/ cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96: 2260-2268, 1995.
7. Kip1, an inhibitor of neointima formation in the rat carotid artery. J. Clin. Invest. 99: 2334-2341, 1997.
8. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684, 1995.
9. Dimri, G. P., M. Nakanishi, P.-Y. Desprez, J. R. Smith, and J. Campisi. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16: 2987-2997, 1996.
10. Dixit, V. M., S. W. Hennessy, G. A. Grant, P. Rotwein, and W. A. Frazier. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. Proc. Natl. Acad. Sci. USA 83: 5449-5453, 1986.
11. Framson, P., and P. Bornstein. A serum response element and binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene. J. Biol. Chem. 268: 4989-4996, 1993.
12. Gibbons, G. H., and V. J. Dzau. Molecular therapies for vascular diseases. Science 272: 689-693, 1996.
13. Good, D. J., P. J. Polverini, F. Rastinejad, M. M. Le Beau, R. S. Lemons, W. A. Frazier, and N. P. Bouck. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87: 6624-6628, 1990.
14. Graña, X., and E. P. Reddy. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
15. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
16. Harper, J. W., and S. J. Elledge. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56-64, 1996.
17. Heichman, K. A., and J. M. Roberts. Rules to replicate by. Cell 79: 557-562, 1994.
18. Iruela-Arispe, M. L., P. Bornstein, and H. Sage. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88: 5026-5030, 1991.
19. Jaffe, E. A., J. T. Ruggiero, and D. J. Falcone. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79-84, 1985.
20. Jaffe, E. A., J. T. Ruggiero, L. K. Leung, M. J. Doyle, McKeown, P. J. Longo, and D. F. Mosher. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl. Acad. Sci. USA 80: 998-1002, 1983.
21. Juliano, R. L., and S. Haskill. Signal transduction from the extracellular matrix. J. Cell Biol. 120: 577-585, 1993.
22. Koyama, H., E. W. Raines, K. E. Bornfeldt, J. M. Roberts, and R. Ross. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell 87: 1069-1078, 1996.
23. LaBaer, J., M. D. Garret, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847-862, 1997.
24. Lawler, J., K. McHenry, M. Duquette, and L. Derick. Characterization of human thrombospondin-4. J. Biol. Chem. 270: 2809-2814, 1995.
25. Lawler, J., H. S. Slayter, and J. E. Coligan. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J. Biol. Chem. 253: 8609-8616, 1978.
26. Liau, G., J. A. Winkles, M. S. Cannon, L. Kuo, and W. M. Chilian. Dietary-induced atherosclerotic lesions have increased levels of acidic FGF mRNA and altered cytoskeletal and extracellular matrix mRNA expression. J. Vasc. Res. 30: 327-332, 1993
27. Majack, R. A., S. C. Cook, and P. Bornstein. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc. Natl. Acad. Sci. USA 83: 9050-9054, 1986.
28. Majack, R. A., S. C. Cook, and P. Bornstein. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell Biol. 101: 1059-1071, 1985.
29. Majack, R. A., L. V. Goodman, and V. M. Dixit. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106: 415-422, 1988.
30. Majack, R. A., J. Mildbrandt, and V. M. Dixit. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J. Biol. Chem. 262: 8821-8825, 1987.
31. McPherson, J., H. Sage, and P. Bornstein. Isolation and Characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J. Biol. Chem. 256: 11330-11336, 1981.
32. Morgan, D. O. Principle of cdk regulation. Nature 374: 131-134, 1995.
33. Mumby, S. M., D. Abbott Brown, D. Raugi, and P. Bornstein. Regulation of thrombospondin secretion by cells in culture. J. Cell. Physiol. 120: 280-288, 1984.
34. Oldberg, A., P. Antonsson, K. Lindblom, and D. Heinegard. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J. Biol. Chem. 267: 22346-22350, 1992.
35. Owens, G. K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75: 487-517, 1995.
36. Parry, D., D. Mahony, K. Wills, and E. Lees. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19: 1775-1783, 1999.
37. Peter, M., and I. Herskowitz. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181-184, 1994.
38. Phan, S. H., R. G. Dillon, B. M. McGarry, and V. M. Dixit. Stimulation of fibroblast proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 163: 56-63, 1989.
39. Pickering, J. G., L. Weir, K. Rosenfield, J. Stetz, J. Jekanowski, and J. M. Isner. Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. J. Am. Coll. Cardiol. 20: 1430-1439, 1992.
40. Prater, C. A., J. Plotkin, D. Jaye, and W. A. Frazier. The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J. Cell Biol. 112: 1031-1040, 1991.
41. Qabar, A. N., Z. Lin, F. W. Wolf, K. S. O'Shea, J. Lawler, and V. M. Dixit. Thrombospondin 3 is a developmentally regulated heparin binding protein. J. Biol. Chem. 269: 1262-1269, 1994.
42. Raugi, G. J., J. S. Mullen, D. H. Barb, T. Okada, and M. R. Mayberg. Thrombospondin deposition in rat carotid artery injury. Am. J. Pathol. 137: 179-185, 1990.
43. Reed, M. J., L. Iruela-Arispe, E. R. O'Brien, T. Truong, T. LaBell, P. Bornstein, and E. H. Sage. Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am. J. Pathol. 147: 1068-1080, 1995.
44. Roth, J. J., V. Gahtan, J. L. Brown, C. Gerhard, V. K. Swami, V. L. Rothman, T. N. Tulenko, and G. P. Tuszynski. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J. Surg. Res. 74: 11-16, 1998.
45. Ruoslathi, E., and Y. Yamaguchi. Proteoglycans as modulators of growth factor activities. Cell 64: 867-869, 1991.
46. Savani, R. C., C. Wang, B. Yang, S. Zhang, M. G. Kinsella, T. N. Wight, R. Stern, D. W. Nance, and E. A. Turley. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin. Invest. 95: 1158-1168, 1995.
47. Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Dürr, and B. Henglein. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92: 11264-11268, 1995.
48. Schulze, A., K. Zerfass-Thome, J. Bergès, S. Middendorp, P. Jansen-Dürr, and B. Henglein. Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16: 4632-4638, 1996.
49. Sherr, C. J. G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
50. Spyridopoulos, I., and V. Andrés. Control of vascular smooth muscle and endothelial cell proliferation and its implication in cardiovascular disease. Front. Biosc. 3: 269-287, 1998.
51. Stouffer, G. A., Z. Hu, M. Sajid, H. Li, G. Jin, M. T. Nakada, S. R. Hanson, and M. S. Runge. β3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 97: 907-915, 1998.
52. Sylvester, A. M., D. Chen, K. Krasinski, and V. Andrés. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J. Clin. Invest. 101: 940-948, 1998.
53. Tanner, F. C., Z.-Y. Yang, E. Duckers, D. Gordon, G. J. Nabel, and E. G. Nabel. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82: 396-403, 1998.
54. Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111: 765-772, 1990.
55. Ueno, H., S. Masuda, S. Nishio, J. J. Li, H. Yamamoto, and A. Takeshita. Adenovirus-mediated transfer of cyclin-dependent kinase inhibitor-p21 suppresses neointimal formation in the balloon-injured rat carotid arteries in vivo. Ann. NY Acad. Sci. 811: 401-411, 1997.
56. Van Zanten, G. H., S. de Graaf, P. J. Slootweg, H. F. G. Heijnen, T. M. Connolly, P. G. de Groot, and J. J. Sixma. Increased platelet deposition on atherosclerotic coronary arteries. J. Clin. Invest. 93: 615-632, 1994.
57. Wang, X.-Q., and W. A. Frazier. The thrombospondin receptor CD47 (IAP) modulates and associates with α2β1 integrin in vascular smoth muscle cells. Mol. Biol. Cell 9: 865-874, 1998.
58. Yang, Z.-Y., R. D. Simari, N. D. Perkins, H. San, D. Gordon, G. J. Nabel, and E. G. Nabel. Role of p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. USA 93: 7905-7910, 1996.
59. Zerfass-Thome, K., A. Schulze, W. Zwerschke, B. Vogt, K. Helin, J. Bartek, B. Henglein, and P. Jansen-Dürr. p27KIP1 blocks cyclin E-dependent transactivation of cyclin Agene expression. Mol. Cell. Biol. 17: 407-415, 1997.